학술논문
Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data
Document Type
Article
Author
Source
In: PharmacoEconomics . (PharmacoEconomics, 1 November 2020, 38(11):1263-1275)
Subject
Language
English
ISSN
11792027
11707690
11707690